*Corresponding Author:
C. Chellaram
Department of Applied Biotechnology, Sur College of Applied Sciences, Sur-411, Sultanate of Oman
E-mail:
chellaramc.sur@cas.edu.om
Date of Received 30 July 2021
Date of Revision 10 May 2022
Date of Acceptance 20 March 2023
Indian J Pharm Sci 2023;85(2):376-387  

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms

Abstract

Salacia oblonga (Celastraceae), a traditional ayurvedic herbal plant commonly called as ponkoranti. The antidiabetic and Histopathological studies of aqueous stem extracts of Salacia oblonga carried in Streptozotocin-nicotinamide induced diabetic rats which were orally treated with glibenclamide and Salacia oblonga stem extracts at lower (250 mg/kg) and higher (500 mg/kg) concentrations. The normal rats were administrated for the oral glucose tolerance test at 0, 30, 60 and 120 min after glucose load. Fasting blood glucose levels were measured by glucose oxidase strips and glucometer. The protective effect was evaluated by studying the effect of antioxidant enzymes, lipid peroxidation and Histopathological changes after the treatment period. Treatment done with 500 mg/kg of stem extract produced more effect with improved protein (1.18±1.45 mg), superoxide dismutase (229.15±1.52 U/mg protein), Catalase (19.51±1.35 U/min/mg protein), Glutathione (1.54±.29 U/min/mg protein), Glutathione peroxidase (1.74±1.56 U/min/mg) and reduced lipid peroxidation (1.76±2.31 μm/min/mg). From the study, it was found that the stem extracts potentially increase the antioxidants and reduced the lipid peroxidation. The rats which were treated with Salacia oblonga and glibenclamide significantly reduced the glucose level (p<0.001). Histopathological alterations were restored after the treatment with stem extracts of Salacia oblonga at lower and higher concentrations. The significant effect on the vital organs such as liver and pancreas demonstrates the herbal usage of potential endangered plant. The spectral analysis (gas chromatography-mass spectrometry) explored the potential natural chemical constituents which were responsible for the antioxidant and antidiabetic activity. Further preclinical and clinical trials are required to confirm the potential of Salacia oblonga stem extract.

Keywords

Salacia oblonga, antidiabetic, streptozotocin, glibenclamide, pancreas

Diabetes mellitus is a metabolic disorder initiated by excess glucose limit in blood. The inadequate secretion of insulin is the major intension in human body[1]. Alpha amylase and alpha glucosidase are the two important enzymes responsible for diabetes[2]. The long-term exposure of increased blood glucose leads to failure of kidney, hypertension, reduce of vision, obesity, tissue damage and lipid disorder[3]. Diabetes arise when our body is inefficacious to take enough insulin effectively or when the pancreas does not generate sufficient insulin[4]. The symptoms are thirsty, abnormal urination, frequent hunger, loss of body weight, headache, long duration for wound healing, skin irritation, loss of vision and tiredness. It causes due to lack of body movement, unhealthy diets, raised blood cholesterol, obesity and glucose[5,6].

Herbal plants play an interesting role in pharmaceutical field and are widely used all over the world for healing purpose. They have rich in therapeutic values and are widely used by pharmaceutical companies. It is possible to extract different chemical constituents from plants, which are active against insects, microorganisms and diseases. The secondary metabolites such as phenols, alkaloids, terpenoids, flavonoids, tannins and saponins are naturally synthesized by the plants through metabolic actions[7]. The medicinal activity of plants can give health, financial and social benefits which are considered as the back bone of traditional medicine. The antidiabetic compounds play an important role in glucose metabolism and reduce the blood sugar level and complications related to diabetes[8,9].

Salacia oblonga (S. oblonga) is a woody strangling climber associated with the family of Celastraceae. Its leaves are oblong, blunt at apex, narrow at base and green color. Flowers are greenish yellow and orange red fruit. It is frequently called as Saptrangi, Ekanayaka and Ponkoranti due to its golden color root bark. The root and stem extractions of S. oblonga used to cure diabetes and obesity[10,11]. It is available in the biosphere reserve of tropical Africa and the southern regions of India and Sri Lanka. In long term analysis, S. oblonga plays an important role in the traditional Ayurveda medicine[12]. The extract of S. oblonga has the similar activity of standard drug acarbose, which is a therapeutic agent of type 2 diabetes[13]. It is also used for curing gonorrhea, asthma, itchiness, joint pain, obesity, thirst and fever. It may reduce the cardiovascular risk in kidney patients[14,15]. The nutrients such as iron, calcium, phosphorous and fiber contents available in S. oblonga can be utilized as liver tonic[16].

In olden period, the root extract of S. oblonga had been used as traditional ayurvedic medicine to cure madhumeha[17]. It is due to the inhibiting action of alpha amylase and alpha glucosidase enzymes. In the present investigation, the stem extract of S. oblonga explores the antidiabetic action and the effect of antioxidant enzymes on diabetic rats. Histopathological alterations of pancreatic tissues of diabetic rats and their effects on higher (500 mg/kg) and lower (250 mg/kg) concentrations of S. oblonga stem extracts uphold the potential action of herb.

Materials and Methods

Chemicals:

Streptozotocin, glibenclamide (Himedia; Mumbai), 2-2-Diphenyl-1-picryl Hydrazyl, glucometer (Accuchek Roche Diagnostics, USA). Semi-autoanalyzer (Photometer 5010, V5+, Germany) with enzymatic kits procured from Primal Healthcare Limited, Lab Diagnostic Division, Mumbai, India. All other chemicals and reagents used are analytical grade.

Collection of plant materials and extract preparation:

Healthy plants of S. oblonga were collected from Western Ghats (15°22'40.5" N, 75°07'41.0" E, Altitude 700 m) Hubli, Dharwad district, Karnataka state, South India. The plant was authenticated by Dr.Vijayakumar, Associate professor, Hindu College, Nagercoil-629002. The stems were separated and washed thoroughly to remove all impurities like soil and dust particles. Then it was cut down into small pieces and dried in shadow for 5 w. The dried stems were powdered by ball mill and maintained at 10°.

Preparation of stem extracts:

About 30 g of dried sample of S. oblonga stem powder was extracted with 300 ml of five different solvents (ethanol (75 %), acetone, water, chloroform and petroleum ether) for one minute using an Ultra Turax mixer (13 000 rpm). It was soaked overnight at room temperature. Then the samples were filtered through Whatman No.1 filter paper in a Buchner funnel, the filtrate was evaporated under vacuum in a rotary evaporator at 40° and then dissolved in respective solvents. Phytochemical studies revealed the maximum percentage of alkaloids, terpenoids, flavonoids, tannins, saponins and other phytochemicals in aqueous stem extract which was used for experimental studies.

Experimental animals:

Adult male albino rats from the KMCH College of Pharmacy, Coimbatore-641048 with the approval of ethical committee were used for the present study. The animals were housed in clean polypropylene cages and maintained with well-ventilated temperature in a controlled animal house with a constant 12 h light/ dark schedule. The animals were fed with standard rat pelleted diet and have provided clean drinking water with ad libitum.

Evaluation of antihyperglycemic activity of S. oblonga:

The antihyperglycemic activity of stem extracts of S. oblonga was committed with the induction of diabetes followed by the oral glucose tolerance test on normal rats.

Experimental induction of diabetes:

The animals were divided into five groups of six animals each. They were kept overnight fasting and the initial fasting blood glucose level checked from the tip of rat tail vein.

Group I: Control (only normal saline); Group II: Streptozotocin (60 mg/kg) (IP)+Nicotinamide 120 mg/kg (p.o); Group III: Streptozotocin (60 mg/ kg)+Nicotinamide 120 mg/kg (p.o) rats treated with Glibenclamide 20 mg/kg (p.o); Group IV: Streptozotocin (60 mg/kg)+Nicotinamide 120 mg/ kg (p.o) rats treated with S. oblonga (250 mg/kg); Group V: Streptozotocin (60 mg/kg)+Nicotinamide 120 mg/kg (p.o) rats treated with S. oblonga (500 mg/kg).

Streptozotocin was dissolved in citrate buffer (pH 4.5) and nicotinamide was dissolved in normal saline. Non-insulin dependent diabetes mellitus was induced in overnight fasted rats by a single intraperitoneal injection of 60 mg/kg streptozotocin, 15 min after the i.p administration of 120 mg/kg of nicotinamide. Hyperglycemia was confirmed by the increased level of blood glucose, and was determined at 72 h. The animals used for the study have blood glucose concentration more than 250 mg/dl[18].

The vehicle (saline), standard glibenclamide and the stem extracts were administered to the respective group animals for 28 d. The fasting blood glucose levels of animals were estimated on 1st, 7th, 14th, 21st and 28th d from the tip of rat tail vein.

Oral glucose tolerance test in normal rats:

Normal rats were subjected for oral glucose tolerance test by the standard procedure[19]. It was carried out with two different concentrations of S. oblonga stem extracts and standard drug glibenclamide. Albino Wistar rats of either sex weighing 150-200 g were divided into 5 groups consisting of 6 rats in each group.

Group I: Distilled water; Group II: Only Glucose (2 g/kg p.o); Group III: Glibenclamide (2 mg/ kg p.o)+Glucose (2 g/kg p.o); Group IV: Extract of S. oblonga (250 mg/kg p.o)+Glucose (2 g/kg p.o); Group V: Extract of S. oblonga (500 mg/kg p.o)+Glucose (2 g/kg p.o)

Distilled water, glibenclamide (2 mg/kg) and S. oblonga stem extracts (250 and 500 mg/kg p.o.) were administered to the respective groups of rats. Glucose (2 g/kg) was fed 30 min after pretreatment with distilled water, glibenclamide and stem extracts. The effect of S. oblonga stem extracts at lower and higher concentrations was measured by testing the glucose level. The blood glucose levels were measured at the interval of 0, 30, 60, 120 and 240 min after glucose load by using blood glucose test strips and glucometer (Accu-chek Advantage II; Roche, Germany).

Determination of antioxidant enzymes and Lipid Peroxidation (LPO):

Antioxidant enzymes such as Superoxide Dismutase (SOD), Catalase (CAT), Glutathione Peroxidase (GPX), reduced Glutathione (GSH) and LPO were determined in the liver tissues of all the tested rats.

Preparation of tissue homogenate:

After the treatment with aqueous stem extracts of S. oblonga with both concentrations, the rats were sacrificed their liver which was secluded. Then it was washed with normal saline and stored for 12 h, for in vivo antioxidant studies. The separated liver was homogenized with motor driven Teflon coated homogenizer with 0.1 M Tris-HCl buffer (pH 7.4) to get 10 % homogenate. The homogenate was centrifuged at 10 000 rpm for 10 min at 5°. The supernatant was used for in vivo antioxidant studies.

Determination of proteins:

Total protein content was determined by Lowry et al.[20]. About 0.1 ml of liver homogenate was mixed with 0.9 ml of water and 4.5 ml of alkaline copper sulphate reagent. The mixture was kept at room temperature for 10 min. About 0.5 ml of Folin’s reagent was added with the mixture. After 20 min, blue colour developed which was measured at 640 nm in a double beam Ultra Violet-Visible (UVVIS) spectrophotometer (UV 1700, Szhimadzhu). The amount of protein present in the sample was expressed as mg/dl.

Determination of SOD:

SOD was measured by the standard method with slight alterations[21]. About 0.5 ml of liver homogenate was diluted with 0.5 ml of distilled water. To this mixture, 0.25 ml of chilled ethanol and 0.15 ml of chloroform were added. The mixture was shaken thoroughly and centrifuged at 2000 rpm. The supernatant solution was separated. About 0.5 ml filtrate was taken separately and 1.5 ml of carbonate buffer (pH 10.2) was added. The reaction was started by the addition of 0.4 ml epinephrine. The change in optical density per minute was measured at 480 nm.

Determination of CAT:

The CAT activity was assayed by the standard method[22]. About 0.1 ml of liver homogenate was taken with 1.0 ml of phosphate buffer (pH 7.0) and hydrogen peroxide (0.2 M). The reaction was arrested by the addition of 0.2 ml dichromate acetic acid reagent. Standard hydrogen peroxide in the range of 4 to 20 μl were taken and treated similarly. The tubes were heated in a boiling water bath for 10 min. The green color developed was read at 570 nm in a Double beam UV-VIS spectrophotometer. CAT activity was expressed as U/mg.

Determination of GPX:

GPX was measured according to the standard procedure[23]. About 0.2 ml each of ethylene diaminetetraacetic acid (0.8 mM), sodium azide (10 mM), reduced GSH (4 mM), hydrogen peroxide (2.5 mM) and 0.4 ml of sodium phosphate buffer (0.32 M) was added with 0.1 ml of liver homogenate. All the ingredients were mixed well and the mixer was incubated at 37° for 10 min. The reaction was arrested by the addition of 0.5 ml of Trichloro acetic acid and the tubes were centrifuged. About 0.5 ml of supernatant was separated and 3 ml of sodium hydrogen phosphate and 1 ml of Ellman's reagent were added. The mixture was kept at room temperature and the color developed was read at 412 nm immediately in a double beam UV-VIS spectrophotometer. GPX activity was expressed as μg/mg.

Determination of reduced GSH:

Reduced GSH was estimated by Ellman’s procedure[24]. About 250 μl of tissue homogenate was taken in a 2 ml Eppendroff tube. Then one ml of 5 % Trichloro acetic acid was added and the solution was centrifuged at 3000 rpm for 10 min at room temperature. The supernatant was separated and 250 μl was taken with 1.5 ml of phosphate buffer (0.2 M) and mixed well. About 250 μl of Ellman’s reagent (0.6 mM) (DTNB solution) was added to the above mixture and the absorbance was measured at 412 nm within 10 min. A standard graph was plotted using GSH reduced solution (1 mg/ml) and GSH content present in the tissue homogenates was calculated by interpolation. Amount of GSH was expressed as μg/ mg protein.

Determination of LPO:

LPO was estimated by the standard method[25]. 1 ml of liver homogenate was mixed with 0.2 ml of sodium dodecyl sulfate (4 % w/v), 1.5 ml 20 % acetic acid in 0.27 M hydrochloric acid (pH 3.5) and 15 ml of 0.8 % thiobarbituric acid (pH 7.4). The mixture was heated in a hot water bath at 85° for 1 h. Then it was cooled and centrifuged for 10 min. The intensity of the pink colour developed was read against a reagent blank at 532 nm.

Histological assessment:

Histopathology is the microscopical study of tissues for the demonstration of pathological alterations. It involves the five different stages such as collection of morbid tissues from necropsy, fixation, preparation of sections, staining and microscopical examination.

Collection and fixation of materials:

Thin pieces of 3 to 5 mm, thickness of pancreatic tissues were collected and gross morbid changes were shown along with normal tissue. The pancreatic tissues were kept in fixative for 24-48 h at room temperature. 10 % of formalin solution was used as fixative. The fixation serves to harden the tissues by coagulating the cell protein, to prevent destruction of tissues, to preserve the structure and to prevent shrinkage.

Haematoxylin and eosin method of staining:

Deparaffine the section, by xylol 5 to 10 min and xylol was removed by absolute alcohol. Then, clean the section in tap water and stained with Haematoxylin for 3-4 min and again cleaned under tap water. The sections were allowed in tap water for few minutes and counter stained with 0.5 % eosin until section appears light pink and then washed with tap water. Then it was blotted and dehydrated in alcohol and cleared with xylol. The section was mounted on a Canada balsam or DPX Mountant and kept the slide dry and remove air bubbles for Histopathological evaluation under photomicroscope (×40).

Spectral analysis of S. oblonga stem extracts:

The natural chemical constituents in S. oblonga stem extract were analysed by using Gas Chromatography– Mass Spectrometry (GC-MS)-5975C Agilent system composed of an auto sampler and a gas chromatograph interfaced with a mass spectrometer. The highest percentage of antioxidant fraction obtained from the aqueous stem extract by Column Chromatography was used for the GC-MS analysis. The important conditions are, column Elite-1 fused silica capillary column (300.25 mm ID×1 EM df, composed of 100 % dimethyl poly siloxane), operating in electron impact mode at 70 eV. A constant flow of 1.51 ml/min and an injection volume 1 μl of helium (99.999 %) gas was used as carrier gas (split ratio 10:1). The temperature of injector and ion source were maintained at 240° and 200° respectively. The oven temperature was programmed from 70° (isothermal for 2 min) with an increase of 10° per min to 300° per min, ending with a 9 min isothermal at 300°. Mass spectra were taken at 70 eV, with a scan range 40-1000 m/z. Solvent cut time was 5 min, MS start time and end time being 5 min and 35 min respectively.

Statistical analysis:

The results of statistical analysis were expressed as mean±Standard Error of Mean (SEM) in the Graph pad 5.1 versions. Statistical significance test for comparison was done by one way ANOVA followed by Dunnett’s Test (n=6); Mean values were tested for the significant difference between the normal control group with diabetic control group (***p<0.001) whereas the treated groups were compared with non treated diabetic control group (***p<0.001, **p<0.01 and *p<0.05).

Results and Discussion

The anti-diabetic action of S. oblonga stem extracts was experimentally confirmed by in vivo study. The effect of oral administration of S. oblonga stem extracts in diabetic rats was determined by measuring the fasting blood glucose level before and after the administration of Streptozotocin and Nicotinamide. The initial blood sugar level was measured for all the five groups of animals. Fasting blood sugar level on 3rd, 10th, 15th and 28th d also measured. There was no significant difference of blood sugar level for the normal control rats identified throughout the experiment. The blood glucose levels of Type-2 diabetic induced control rats were increased from the initial level 80±4.131 mg/dl to 463.33±47.164 mg/ dl on the next interval of the experiment. Diabetic control rats showed significantly increased level (***p˂0.001) of blood glucose compared with normal control rats. The stem extracts of S. oblonga at the concentration of 250 mg/kg p.o. reduced the blood glucose level from 466±67.26 mg/dl to 133.33±14.29 mg/dl and the same extract at higher concentration (500 mg/kg p.o.) potentially reduced the blood glucose level from 430±57.677 mg/dl to 126.67±12.56 mg/dl. These results explored the stem extracts of S. oblonga significantly cut the blood glucose level almost similar to the standard drug glibenclamide, which reduce the blood glucose level from 426.66±52.578 mg/dl to 181.67±8.33 mg/dl on 28th d. There was a significant reduction of blood glucose level observed in treated diabetic groups with glibenclamide (***p˂0.001) and S. oblonga stem extracts 250 mg/kg p.o. and 500 mg/kg p.o (*p˂0.05) when compared with the non treated diabetic group. The variation of blood glucose levels at each interval was represented in the figure (fig. 1).

IJPS-stems

Fig. 1: Antihyperglycemic activity of S. oblonga stems extracts in diabetic rats
Note: A: Fasting blood glucose level at 0 h; B: Fasting blood glucose level after 72 h; C: Fasting blood glucose level on 10th d; D: Fasting blood glucose level 15th d; E: Fasting blood glucose level on 28th d; Group I: Normal control; Group II: Untreated diabetic rats (Streptozotocin+Nicotinamide); Group III : Diabetic rats treated with Glibenclamide (Standard); Group IV: Diabetic rats treated with S. oblonga (250 mg/kg); Group V : Diabetic rats treated with S. oblonga (500 mg/kg); Data are represented as mean±SEM (n=6 per group); mean values were tested for the significant difference between the normal control group with diabetic control group (***p<0.001) whereas the treated groups were compared with non-treated diabetic control group (***p˂0.001, **p˂0.01 and *p˂0.05)

The hyperglycemia appears due to the excess production of glucose from hepatic and it leads to serious disorder[26]. Streptozotocin and nicotinamide induced Type-2 diabetic rats produced high blood glucose level. Generally, Nicotinamide is administered to protect the insulin secreting cells against streptozotocin. Thus the beta cells are not completely damaged and it is used to induce Type 2 diabetes. In the present study, there was a significant reduction of glucose level at the concentration of 500 mg/kg p.o. of stem extract of S. oblonga than 250 mg/kg p.o. extract. Similar studies carried out on the root extracts of S. oblonga, leaf and root extract of Andrographis paniculata, Tinospora cordifolia and Trigonella foenum-graecum corroborate the glucose reduction potential of herbal plants[27-28]. The phytochemicals such as phenols, flavonoids, terpenoids, tannins, alkaloids and saponins are responsible for antidiabetic action[29].

The ability of body to take glucose can be estimated by glucose tolerance test on normal rats. In oral glucose tolerance test, the blood samples were analyzed at 0, 60, 120,180 and 240 min intervals. Initially, the concentration of blood glucose level was seen normal and slight change among the different groups. The blood glucose level was rapidly increased after glucose loading at the 1st h interval. The glucose levels of treated groups were not significant at the 1st and 2nd h interval. The treated groups with glibenclamide and S. oblonga stem extracts (250 mg/ kg p.o. and 500 mg/kg p.o.) were showed significant reduction of glucose level (***p˂0.001) from the 4th to 5th h interval when compared with control rats. The changes in the blood glucose level of treated groups and diabetic control were shown in the Table 1.

Glucose Level Control Only Glucose Glucose+STD Glucose+Ext L.D Glucose+Ext H.D
Initial 55±17.99 52±16.85 47.83±15.82 57.83±18.9 60±19.81
1st h 78.33±4.94 273±122.7ns 240±108.4ns 198.3±94.88ns 191±86.08ns
2nd h 75±3.16 253.3±113.4ns 186.7±83.89ns 165±74.73ns 145.7±65.52ns
3rd h 83.33±5.72 238.3±17.4*** 215±2.88*** 226.7±4.41*** 218.3±6.009***
4th h 81.67±3.33 199.3±6.546*** 171.7±6.91*** 183.3±3.801*** 173.3±4.59***
5th h 79.83±4.61 84.17±37.96 48.17±21.76 57±25.53 53±23.77

Table 1:  Effects of S. Oblonga Stem Extracts in Normal Rats by Oral Glucose Tolerance Test

Generally, oral glucose tolerance test measures the body’s ability to use glucose. It is used to diagnose the pre-diabetes and diabetes mellitus. The present study supports the active potential of aqueous stem extract of S. oblonga at higher and lower concentrations. Similar studies carried out in the ethanol extract of Hedyotis leschenaultiana and Cynoglossum zeylanicum has been proven as a potential drug for diabetic complications[30,31]. The oral glucose tolerance test conducted on the extract of Phyllanthus acidus shown the nontoxic nature of plant at lower concentration[32]. The hypoglycemic effect of plant extracts were due to the presence of flavonoids, terpenoids, saponins and other secondary metabolites[33]. The antihyperglycemic effect of stem extract of S. oblonga was compared with the standard Glibenclamide which confirmed the potentiality of herbal extract.

After the treatment of 28 d, the liver antioxidants such as protein, SOD, CAT, reduced GSH, GPX and LPO were measured. The diabetic control rats showed reduction in the protein, SOD, CAT, GSH and GPX which inferred the continuous oxidative stress. The diabetic rats treated with the standard glibenclamide and S. oblonga stem extracts (250 mg/kg p.o. and 500 mg/kg p.o.) significantly increased the level of antioxidant enzymes (***p˂0.001) when compared with the diabetic group of rats which explored the reduction of reactive oxygen species. Treatment done with 500 mg/kg of stem extract produced improved protein (1.18±1.45 mg), SOD (229.15±1.52 U/mg protein), CAT (19.51±1.35 U/min/mg protein), GSH (1.54±.29 U/min/mg protein) and GPX (1.74±1.56 U/min/mg). The present study indicates the stem extract of S. oblonga could be a potent source for antioxidants.

LPO leads cell damage, which was measured for all the group of rats. There was an increase of LPO (2.08±1.10 μm/min/mg of protein) for the streptozotocin and nicotinamide induced diabetic rats. The LPO tendency was also measured for the treated rats with glibenclamide and stem extracts (250 mg/kg p.o. and 500 mg/kg p.o.) 1.56±1.06, 1.90±1.26 and 1.76±2.31 and μm/min/mg of protein respectively. The treated groups showed significant reduction (***p˂0.001) of LPO when compared with diabetic control rats. The effect of oral administration of S. oblonga on liver antioxidants of streptozotocin and nicotinamide induced diabetic rats were graphically represented in the fig. 2. From the study, it was found that the action of stem extracts significantly increase the antioxidants and reduce the LPO.

IJPS-liver

Fig. 2: Effects of S. oblonga stem extract on liver antioxidants and lipid peroxidation in diabetic rats
Note: Group I: Normal control; Group II: Untreated diabetic rats (Streptozotocin+Nicotinamide) Group III: Diabetic rats treated with Glibenclamide (Standard); Group IV: Diabetic rats treated with S. oblonga (250 mg/kg); Group V: Diabetic rats treated with S. oblonga (500 mg/kg); data are represented as mean±SEM (n=6/group); mean values were tested for the significant difference between the normal control group with diabetic control group (***p<0.001) whereas the treated groups were compared with non-treated diabetic control group (***p˂0.001)

The clinical studies and experiments carried out on diabetes suggested that it was linked with oxidative stress, strain, reactive oxygen species, hydrogen peroxide and hydroxyl radicals[34]. Free radicals play an important role for the damage of beta cells.

Streptozotocin induced diabetes can produce reactive species leads the damage of important organs in our body like kidney, liver and eyes[35]. A variation in defense system may alter the antioxidant enzymes such as SOD, CAT, GSH, and GPX. The enzymes such as SOD, GSH and CAT play vital role for the elimination of reactive oxygen species. They are considered as first line defense antioxidants[36]. The hydrogen peroxide produced by SOD is removed as water by the action of other enzymes GSH, GPX and CAT. Thus our body is preserved from the toxic nature of oxygen radical. In the present study, the liver antioxidants such as SOD, CAT, GSH and GPX were reduced in diabetic control rats than normal rats. It specified the inactiveness of defense system. Many investigators proved the diminishing nature of antioxidants on diabetic rats[37]. Similar results were reported on the studies carried out on the root extracts of S. oblonga and Moringa oleifera leaves. The decreased antioxidant enzymes were improved by the treatment of root extracts and leaf extracts[38,39]. It supports that the stem extract of S. oblonga be a potent source for the increase of antioxidant enzymes at lower and higher concentrations.

LPO is the most important one for chronic diabetes. It may induce inflammation and many diabetic complications[40]. The anti-LPO study conducted on the root extract of S. oblonga effectively reduces the LPO[41]. In the present study, LPO severely increased for the diabetic rats. Then it was decreased by the treatment of stem extracts of S. oblonga and the results were compared to the standard. Similar studies carried out on Morin effectively reduce the LPO on diabetic rats[42].

The Histopathological studies were carried out on the pancreas of normal, diabetic and treated groups (glibenclamide and S. oblonga stem extracts (250 mg/kg p.o. and 500 mg/kg p.o.) of experimental rats. The histological effects of stem extracts on rat pancreas were shown by the arrow mark in the photomicrograph (x40) of fig. 3. The section of normal rat pancreas was shown normal acini and the section from islets also normal in number and size. There is no evidence of inflammation or cytoplasmic vacuolation seen in the section studied. The photomicrograph of the pancreatic section of untreated diabetic rats was shown normal acini but the islets were shown cytoplasmic vacuolation and decreased in number. The pancreatic section of diabetic rats treated with glibenclamide was shown normal acini and the section from islets shown normal in number and size. There was no evidence of cytoplasmic vacuolation seen in the section studied. Comparison of normal and diabetic groups clearly shows the destruction of islet cells in diabetic rats as they were irregularly shaped and atrophic.

IJPS-rat

Fig. 3:Histopathological effects of S. oblonga stem extract on rat pancreas
Note: Histopathological effects on A: Haematoxylin and eosin stained sections of pancreas of normal control rats illustrating normal islets of Langerhans (40x); B: Pancreatic section of diabetic untreated rat showing cytoplasmic vacuolation and decreased number of islets of Langerhans (40x); C: Pancreatic section of diabetic rats treated with Glibenclamide showing normal islets in number and size and no evidence for cytoplasmic vacuolation (40x); D: S. oblonga treated (250 mg/kg p.o.) diabetic rat pancreas showing the islets of Langerhans in normal size and number and focal cytoplasmic vacuolation seen in the section (40x); E: S. oblonga treated (500 mg/kg p.o.) diabetic rat pancreas showing normal islets in number and size and no evidence for cytoplasmic vacuolation (40x)

Haematoxylin and eosin sections of the diabetic rat pancreas treated with aqueous stem extracts of S. oblonga at 250 mg/kg p.o. and 500 mg/kg p.o. concentrations were shown normal acini and the section from islets shown normal in number and size but focal cytoplasmic vacuolation seen in the section treated with lower concentration of stem extract. The histological effect of diabetic rats treated with 500 mg/kg p.o. extracts shown no evidence of inflammation or cytoplasmic vacuolation. This finding is in agreement with the previous study [43].

The Histopathological studies carried out on the pancreatic tissues of diabetic rats to confirm the antihyperglycemic action of S. oblonga stem extracts. In this study the Histopathological examination of sections of the pancreas from the diabetic control group of rats showed massive pathological changes as compared to the normal structure observed in the normal group. The photomicrograph of beta cells in the pancreatic islets of the normal rats was looks like patches. Destruction of beta cells reflects the cytotoxity of streptozotocin. Microscopic examination of pancreatic sections of the untreated diabetic group revealed a breakdown of anatomical features including necrotic changes, beta cell degranulation and severe vacuolation. From the previous study, cluster of inflammation cells could also be seen among the cells[44]. The diabetic rats treated with 500 mg/kg p.o of aqueous stem extract of S. oblonga shows maximum number in the regeneration of beta-cells than 250 mg/kg p.o. Similar histological studies were carried out on the pancreas of diabetic rats by using the root extract of S. oblonga, reduced diabetes and the tissues were normal after treatment[45].

The natural phytoconstituents superintend the pharmaceutical characteristics of stem extract of S. oblonga. They are exposed by comparing the spectral data obtained on the GC-MS with the data base of National Institute Standard and Technology (NIST) having more than 62 000 patterns. The name of the natural chemical constituents and their structure were identified with the help of mass spectrum obtained. The GC-MS chromatogram of the stem extract of S. oblonga was represented in the fig. 4. There are fifteen bioactive compounds were identified and was represented in the Table 2 with their name, structure and molecular weight.

IJPS-extract

Fig. 4: GC-MS chromatogram of the stem extract of S. oblonga

S No RT Name of the chemical component Molecular formula Molecular weight (g/mol) Peak area % Structure
1 5.618 1-silacylo-2,4-hexadiene C5H6Si 94 0.54
2 5.91 sulfuric acid, dimethyl ester C2H6O4S 126 2.07
3 9.636 glycerine C3H8O3 92 2.75
4 12.7 3H-pyrazol-3-one, 1,2-dihydro-1,2,5-trimethyl- C6H10N2O 126 0.25
5 14.58 1,2,3,4-butanetetrol, [S-(R*,R*)]- C4H10O4 122 6.52
6 14.78 1,2-ethanediol, 1-(2-phenyl-1,3,2-dioxaborolan-4-yl)-, [S-(R*,R*)]- C10H13BO4 208 1.29
7 15.3 benzene, 1-(1,5-dimethyl-4-hexenyl)-4-methyl- C15H22 202 0.35
8 20.78 hexadecanoic acid, methyl ester C17H34O2 270 1.55
9 21.73 n-hexadecanoic acid C16H32O2 256 19.65
10 23.01 heptadecanoic acid C17H34O2 270 0.49
11 23.46 10,13-octadecadienoic acid, methyl ester C19H34O2 294 4.33
12 23.58 9-octadecenoic acid (Z)-, methyl ester, C19H36O2 296 5.47
13 23.89 methyl stearate C19H38O2 298 1.64
14 24.44 6-octadecenoic acid C18H34O2 282 42.09
15 24.61 octadecanoic acid C18H36O2 284 11.01

Table 2: Chemical Compounds Identified using GC-MS Analysis

Among the natural compounds obtained, hexadecanoic acid methyl ester has proven as antidiabetic compound[46], 9-octadecenoic acid methyl ester can inhibit alpha glucosidase enzyme, 10,13-octadecadienoic acid methyl ester is an hepatoprotective agent which can protect liver from oxidative stress and free radicals. The antioxidant, n-hexadecanoic acid can protect our body from tissue damage[48] and the heptadecanoic acid can prevent pre-diabetes from human[49]. Similar studies were done by researchers on herbal extractions, explored the pharmaceutical biological activities[50].

In conclusion, the natural chemical constituents present in the stem extracts of S. oblonga were responsible for the potential pharmaceutical properties. The aqueous stem extract beneficially reduce the glucose level, LPO and increase the level of liver antioxidants. The Histopathological effects on the pancreas of diabetic rats by the action of stem extracts proved the antidiabetic potential of herbal plant S. oblonga. However more studies are entailed to isolate and characterize the active antidiabetic compounds from the aqueous stem extracts of S. oblonga.

Ethical statement:

All animal procedures were performed after the approval from the Institutional Animal Ethics Committee, KMCH College of Pharmacy, Coimbatore (Reg.No: 685/PO/ Re/S/2002/CPCSEA) and by the suggestions for the perfect care and utilization of laboratory animals.

Acknowledgements:

The authors would like to express gratitude for the KMCH college of Pharmacy, Coimbatore to provide lab facilities and the Chairman and Principal of Veltech Multitech Engineering College to give support to complete the research work successfully.

Conflict of interest:

The authors disclosed no conflict of interest.

References